Reishi increases significantly IFN-γ, IL-2, IL-6, and NK cells (CD56 + cells) levels in lung cancer patients thereby increasing potentially immune therapies (Gao et al., 2003). This evidence concerns the gene NCAM1 and lung carcinoma.